Codexis (CDXS) Debt to Equity (2017 - 2026)
Codexis (CDXS) recorded quarterly Debt to Equity of $0.94 in Q1 2026, up 17.97% quarter-over-quarter from $0.79 in Q4 2025, and up 59.22% on a YoY basis from $0.59 in Q1 2025.
Codexis (CDXS) Debt to Equity (2017 - 2026) Analysis & Trends
Codexis' Debt to Equity history runs 5 years deep, the most recent figure standing at $0.94 for Q1 2026.
- In Q1 2026, Debt to Equity rose 59.22% year-over-year to $0.94; the TTM figure through Mar 2026 stood at $0.94 (up 59.22% YoY), while the FY2025 annual figure was $0.79, up 83.77% from the prior year.
- Debt to Equity was $0.94 for Q1 2026 at Codexis, up from $0.79 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $1.03 in Q3 2025 to a low of $0.35 in Q1 2024.
- Historically, Debt to Equity has averaged $0.63 across 3 years, with a median of $0.59 in 2025.
- Biggest YoY gain for Debt to Equity was 164.25% in 2025; the steepest drop was 53.32% in 2025.
- A 3-year view of Debt to Equity shows it stood at $0.43 in 2024, then soared by 83.77% to $0.79 in 2025, then climbed by 17.97% to $0.94 in 2026.
- The last three Debt to Equity figures came in at $0.94 (Q1 2026), $0.79 (Q4 2025), and $1.03 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 0.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.94 |
| Dec 31, 2025 | 0.79 |
| Sep 30, 2025 | 1.03 |
| Jun 30, 2025 | 0.71 |
| Mar 31, 2025 | 0.59 |
| Dec 31, 2024 | 0.43 |
| Sep 30, 2024 | 0.39 |
| Jun 30, 2024 | 0.46 |
| Mar 31, 2024 | 0.35 |
| Sep 30, 2018 | 0.00 |
| Jun 30, 2018 | 0.00 |
| Mar 31, 2018 | 0.02 |
| Dec 31, 2017 | 0.01 |
| Sep 30, 2017 | 0.02 |
| Jun 30, 2017 | 0.01 |
| Mar 31, 2017 | 0.02 |